Clinical Trial Update: Respimat® Inhaler vs a Metered Dose Inhaler Using Berodual® in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing the Respimat inhaler with a metered-dose inhaler using Berodual in patients with chronic obstructive pulmonary disease has be…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Berodual (ipratropium bromide + fenoterol)
• Respimat inhaler

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 3 | Status: TERMINATED